Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice

被引:20
|
作者
Ochiai, Masaru [1 ]
Takeuchi, Toshiki [2 ]
Nozaki, Tsutomu [3 ]
Ishihara, Ken-o [3 ]
Matsuo, Tatsuhiro [2 ]
机构
[1] Kitasato Univ, Sch Vet Med, 23-35-1 Higashi, Towada, Aomori 0348628, Japan
[2] Kagawa Univ, Fac Agr, Kita Ku, 2393 Ikenobe, Miki, Kagawa 7610795, Japan
[3] BHN Co Ltd, Chiyoda Ku, 1-16 Kandanishiki, Tokyo 1010054, Japan
关键词
fat accumulation; glucose tolerance; Kaempferia parviflora; methoxy flavone; PPAR; ETHYL-ACETATE EXTRACT; TISSUE DISTRIBUTION; INSULIN-RESISTANCE; PANCREATIC LIPASE; PPAR-GAMMA; 5,7-DIMETHOXYFLAVONE; MOUSE; RAT; POLYMETHOXYFLAVONOIDS; PHARMACOKINETICS;
D O I
10.1111/1750-3841.14437
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
This study assessed the effect of Kaempferia parviflora, also known as black ginger (BG), and its ethanol extract (BGE) on peroxisome proliferator-activated receptor (PPAR) agonistic activity, glucose tolerance, fat accumulation, and lipids-induced hypertriglyceridemia in mice. PPAR ligand-binding capacity in vitro and polymethoxy flavone contents were highly observed in organic solvent extracts. In an animal experiment A, male diabetic Nagoya-Shibata-Yasuda mice were divided into five dietary groups and fed each diet for 8 weeks: AIN-93G diet (low-fat [LF] diet), high-fat (HF) diet, HF diet supplemented with 1% BG, HF diet supplemented with 0.19% BGE, and HF diet supplemented with pioglitazone (PPAR agonist, 3 mg/kg/day) as a PPAR agonistic positive control. As determined from glucose and insulin tolerance tests, plasma glucose levels were improved in the BG and BGE groups. The BGE extract suppressed fat accumulation in adipose tissues, liver, and muscles without changing the plasma adiponectin level. In an animal experiment B, in order to investigate the effect of BG and BGE on lipid-induced hypertriglyceridemia, male ddY mice were divided into three test groups: control, BG-administered group (500 mg/kg), and BGE-administered group (100 mg/kg). The plasma triacylglycerol level was not different among the groups during the lipids administration test. These results conclude that the BGE extract containing several kinds of polymethoxy flavones showed PPAR ligand-binding capacity in vitro and prevented obesity and insulin resistance independent of adiponectin secretion in mice.
引用
收藏
页码:339 / 348
页数:10
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
    Qin, Xiaomei
    Xie, Xuefen
    Fan, Yanbo
    Tian, Jianwei
    Guan, Youfei
    Wang, Xian
    Zhu, Yi
    Wang, Nanping
    HEPATOLOGY, 2008, 48 (02) : 432 - 441
  • [42] The Selective Peroxisome Proliferator-Activated Receptor-Delta Agonist Seladelpar Reverses Nonalcoholic Steatohepatitis Pathology by Abrogating Lipotoxicity in Diabetic Obese Mice
    Haczeyni, Fahrettin
    Wang, Hans
    Barn, Vanessa
    Mridha, Auvro R.
    Yeh, Matthew M.
    Haigh, W. Geoffrey
    Ioannou, George N.
    Choi, Yun-Jung
    McWherter, Charles A.
    Teoh, Narcissus C. -H.
    Farrell, Geoffrey C.
    HEPATOLOGY COMMUNICATIONS, 2017, 1 (07) : 663 - 674
  • [43] Adipose Tissue Fat Accumulation Is Reduced by a Single Intraperitoneal Injection of Peroxisome Proliferator-Activated Receptor Gamma Agonist When Given to Newly Hatched Chicks
    Sato, K.
    Matsushita, K.
    Matsubara, Y.
    Kamada, T.
    Akiba, Y.
    POULTRY SCIENCE, 2008, 87 (11) : 2281 - 2286
  • [44] Peroxisome Proliferator-Activated Receptor-δ Induces Insulin-induced Gene-1 and Suppresses Hepatic Lipogenesis in Obese Diabetic Mice
    Sharma, Rajeev
    Torka, Pallawi
    HEPATOLOGY, 2008, 48 (06) : 2085 - 2085
  • [45] Ginger extract prevents high-fat diet-induced obesity in mice via activation of the peroxisome proliferator-activated receptor δ pathway
    Misawa, Koichi
    Hashizume, Kojiro
    Yamamoto, Masaki
    Minegishi, Yoshihiko
    Hase, Tadashi
    Shimotoyodome, Akira
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2015, 26 (10): : 1058 - 1067
  • [46] Activation of peroxisome proliferator-activated receptor-α (PPARα) in proximal intestine improves postprandial lipidemia in obese diabetic KK-Ay mice
    Kimura, Rino
    Takahashi, Nobuyuki
    Goto, Tsuyoshi
    Murota, Kaeko
    Kawada, Teruo
    OBESITY RESEARCH & CLINICAL PRACTICE, 2013, 7 (05) : E353 - E360
  • [47] FK-614, a selective peroxisome proliferator-activated receptor γ agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs
    Uchino, H
    Kim, T
    Lam, TKT
    Yoshii, H
    Klement, P
    Williams, W
    Kawamori, R
    Giacca, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (09): : 1250 - 1258
  • [48] Crystal Structures of the Human Peroxisome Proliferator-Activated Receptor (PPAR)α Ligand-Binding Domain in Complexes with a Series of Phenylpropanoic Acid Derivatives Generated by a Ligand-Exchange Soaking Method
    Oyama, Takuji
    Kamata, Shotaro
    Ishii, Isao
    Miyachic, Hiroyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (09) : 1202 - 1209
  • [49] A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
    Ngala, R. A.
    Stocker, C. J.
    Roy, A. G.
    Hislop, D.
    Wargent, E.
    Bell, R.
    Hassall, D. G.
    Harling, J. D.
    Billin, A. N.
    Willson, T. M.
    Arch, J. R. S.
    Cawthorne, M. A.
    DIABETES OBESITY & METABOLISM, 2011, 13 (05): : 455 - 464
  • [50] Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor Agonist Treatment Reduces Amyloid Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
    Skerrett, Rebecca
    Pellegrino, Mateus P.
    Casali, Brad T.
    Taraboanta, Laura
    Landreth, Gary E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (35) : 21591 - 21602